128 related articles for article (PubMed ID: 19674382)
1. Algorithm-guided treatment versus treatment as usual for major depression.
Yoshino A; Sawamura T; Kobayashi N; Kurauchi S; Matsumoto A; Nomura S
Psychiatry Clin Neurosci; 2009 Oct; 63(5):652-7. PubMed ID: 19674382
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression.
Bauer M; Pfennig A; Linden M; Smolka MN; Neu P; Adli M
J Clin Psychopharmacol; 2009 Aug; 29(4):327-33. PubMed ID: 19593170
[TBL] [Abstract][Full Text] [Related]
3. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
[TBL] [Abstract][Full Text] [Related]
4. Challenges and algorithm-guided treatment in major depressive disorder.
Shelton RC; Trivedi MH
J Clin Psychiatry; 2011 Apr; 72(4):e14. PubMed ID: 21527120
[TBL] [Abstract][Full Text] [Related]
5. Treating major depression: antidepressant algorithms.
Thase ME
J Clin Psychiatry; 2009 Dec; 70(12):e46. PubMed ID: 20141703
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the efficacy and moderators of algorithm-guided antidepressant treatments of major depressive disorder.
Zhang H; Wu Z; Cao L; Su Y; Wang F; Hong W; Cai Y; Peng D; Fang Y
J Affect Disord; 2022 Jan; 297():68-75. PubMed ID: 34670132
[TBL] [Abstract][Full Text] [Related]
7. Update on partial response in depression.
Thase ME
J Clin Psychiatry; 2009; 70 Suppl 6():4-9. PubMed ID: 19922738
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
Okamura M; Akizuki N; Nakano T; Shimizu K; Ito T; Akechi T; Uchitomi Y
Psychooncology; 2008 Feb; 17(2):154-60. PubMed ID: 17461435
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic and therapeutic strategies in treatment-resistant depression. Augmentation strategies.
Thase ME
CNS Spectr; 2009 Mar; 14(3 Suppl 4):7-10. PubMed ID: 19407714
[No Abstract] [Full Text] [Related]
10. Augmenting antidepressants with folate: a clinical perspective.
Fava M
J Clin Psychiatry; 2007; 68 Suppl 10():4-7. PubMed ID: 17900202
[TBL] [Abstract][Full Text] [Related]
11. Achieving remission in major depressive disorder: the first step to long-term recovery.
Kelsey JE
J Am Osteopath Assoc; 2004 Mar; 104(3 Suppl 3):S6-10. PubMed ID: 15083991
[TBL] [Abstract][Full Text] [Related]
12. Outcome of late-life depression after 3 years of sequential treatment.
Kok RM; Nolen WA; Heeren TJ
Acta Psychiatr Scand; 2009 Apr; 119(4):274-81. PubMed ID: 19053970
[TBL] [Abstract][Full Text] [Related]
13. Treatment-resistant depression.
Little A
Am Fam Physician; 2009 Jul; 80(2):167-72. PubMed ID: 19621857
[TBL] [Abstract][Full Text] [Related]
14. Treating partial responders to antidepressant treatment.
Trivedi MH
J Clin Psychiatry; 2009 Sep; 70(9):e31. PubMed ID: 19818237
[TBL] [Abstract][Full Text] [Related]
15. Remission of depression and the Texas Medication Algorithm Project.
Trivedi MH
Manag Care Interface; 2003; Suppl B():9-13. PubMed ID: 12647607
[No Abstract] [Full Text] [Related]
16. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
17. Algorithms for the pharmacotherapy of major depression.
Shioe K; Kanba S
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S77-82. PubMed ID: 10560904
[TBL] [Abstract][Full Text] [Related]
18. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
[TBL] [Abstract][Full Text] [Related]
19. Using treatment algorithms to bring patients to remission.
Trivedi MH
J Clin Psychiatry; 2003; 64 Suppl 2():8-13. PubMed ID: 12625793
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
